Robert H.Lurie Comprehensive Cancer Center — Chicago, Illinois

Robert H.Lurie Comprehensive Cancer Center is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Clinical Trials Trust Score: 21/100 (FAILING). This profile has not yet been claimed by the site owner.

Robert H.Lurie Comprehensive Cancer Center has participated in 19 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumor, BRAF V600 Mutation, Multiple Myeloma.

Sponsors: ABM Therapeutics Corporation, Pharmacyclics LLC., ISA Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 21/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Robert H.Lurie Comprehensive Cancer Center?

Robert H.Lurie Comprehensive Cancer Center has a Crixeo Trust Score of 21/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Robert H.Lurie Comprehensive Cancer Center conducted?

Robert H.Lurie Comprehensive Cancer Center has 19 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumor, BRAF V600 Mutation, Multiple Myeloma.

Is Robert H.Lurie Comprehensive Cancer Center accredited by Crixeo Clinical Trials?

Robert H.Lurie Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Robert H.Lurie Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.